Enable Biosciences Inc.
South San Francisco, CA
- UEI
- D82RA1JMEBA8
- CAGE
- 7FSW3
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 510 Myrtle Ave # 101, South San Francisco, CA 94080, USA
- Website
- enablebiosciences.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
SBA capabilities narrative
Research, design and development of ultra-sensitive and ultra-specific antibody detection assays for research and and clinical use in infectious, autoimmune and neoplastic diseases
Quick answers
Is Enable Biosciences Inc. registered in SAM.gov?
Yes. Enable Biosciences Inc.'s SAM.gov registration is active through June 25, 2027.
What is Enable Biosciences Inc.'s most recent federal award?
Enable Biosciences Inc.'s most recent federal grant award is Development of an automated high-throughput dried blood spot assay to facilitate large scale screening for type 1… (R44DK124009), from National Institute of Diabetes and Digestive and Kidney Diseases (NIH), on September 19, 2019.
On GovTribe
See Enable Biosciences Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors